Efficacy of Vonoprazan-Based Triple Therapy with Sitafloxacin and Amoxicillin for Third-Line Helicobacter pylori Eradication: A Multicenter Prospective Analysis on Drug Resistance and gyrA Mutations
Overall, the 7-day VAS regimen exhibited an excellent safety profile and efficacy as a third-line eradication treatment, even against gyrA mutation-positive H. pylori strains.
Authors
- Juntaro Matsuzaki (ORCID: https://orcid.org/0000-0002-3204-5049)
- Kenro Hirata (ORCID: https://orcid.org/0000-0003-4536-7781)
- Tatsuhiro Masaoka
- Hiroyuki Imaeda (ORCID: https://orcid.org/0000-0003-0898-6540)
- Takanori Kanai∥ (ORCID: https://orcid.org/0000-0002-1466-4532)
- Atsushi Nakazawa
- Hideki Mori (ORCID: https://orcid.org/0000-0001-8830-4671)
- Masahiro Yoshioka (ORCID: https://orcid.org/0000-0001-7037-7768)
- Akira Okazawa
- Hidekazu Suzuki (ORCID: https://orcid.org/0000-0002-8994-6163)
- Shunpei Wasaki
Institutions
- Tokai University (JP)
- Keio University (JP)
- Tokyo Medical Center (JP)
- Kawasaki Municipal Hospital (JP)
- Saitama Medical University Hospital (JP)
- Saiseikai Central Hospital (JP)
- National Hospital Organization (JP)
- Nippon Koei (Japan) (JP)
- keiyu Hospital (JP)
Publication Details
- Journal
- Digestive Diseases
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1159/000546914
- Citations
- 2
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01